Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition.

Mobin KhoramjooKaiming WangKarthik SrinivasanMahmoud GheblawiRupasri MandalSimon RousseauDavid WishartVinay PrasadLawrence RicherAngela M CheungGavin Y Oudit

Published in: PloS one (2024)

Taurine emerges as a promising predictive biomarker and potential therapeutic target in PCC. Taurine supplementation has already demonstrated clinical benefits in various diseases and warrants exploration in large-scale clinical trials for alleviating PCC.

Keyphrases

clinical trial
coronavirus disease
sars cov
randomized controlled trial
risk assessment
respiratory syndrome coronavirus
double blind